Alcon 3Q profit falls on Novartis deal costs
Alcon Inc., which makes treatments for glaucoma and eye infections, said Wednesday its third-quarter net income fell 13 percent on costs related to its majority takeover by fellow Swiss drugmaker Novartis SA. Still the results topped analysts' expect...